M. Lenziardi et al., PRESENCE OF ENDOTHELIN-1 IN THE NORMAL AND PATHOLOGICAL HUMAN THYROID, Journal of endocrinological investigation, 18(5), 1995, pp. 336-340
An immunohistochemical study with two rabbit polyclonal antibodies I-A
R76 and CA-08-351 against Endothelin-1 (ET-1) was performed in 133 hum
an thyroid specimens: 5 normal thyroids, 30 multinodular goiters (15 t
oxic and 15 nontoxic), 20 Graves' diseases, 5 Hashimoto's thyroiditis,
26 adenomas (6 Hurthle cell, 16 toxic and 4 nontoxic), 30 classic pap
illary carcinomas, 3 minimally invasive follicular carcinomas, 1 widel
y invasive follicular carcinoma, 3 undifferentiated carcinomas and 10
medullary carcinoma. All normal thyroids, non toxic multinodular goite
rs and non toxic adenomas, 4 (66%) Hurthle cell adenomas, 3 (15%) Grav
es' diseases, 1 (33%) case of minimally invasive follicular carcinoma
showed rare follicular cells with weak cytoplasmic immunoreactivity. M
any immunoreactive follicular cells, with or without oxyphilic changes
, were observed in all specimens of Hashimoto's disease, while the lym
phocytic infiltrate was always negative. Twenty-seven (90%) classic pa
pillary carcinomas were positive. Immunoreactivity was intracytoplasmi
c, weak in 14 cases and intense in 13. The cells of toxic adenoma and
toxic multinodular goiter were negative, whereas the acellular stroma
was intensely posit:ive in both cases. Medullary and undifferentiated
carcinomas were negative. These results show ET-1 immunoreactivity in
normal and pathological human thyroids. In particular, the high conten
t of this peptide in the thyroid papillary carcinoma suggests that ET-
1, whose mitogenic role has recently been emphasized, could be involve
d in the growth of this tumor.